Avita Medical Stock Forecast
NASDAQ: RCELHealthcareMedical DevicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RCEL analyst consensus
Consensus (3 analysts)
none
Avg. price target
$12.03-7.82%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 3 Wall Street analysts covering Avita Medical (2026-10-08), 3 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $12.03, with a high estimate of $13.66 and a low estimate of $10.79. The average target implies downside of 7.8% from the current price of $13.05.
The spread between the highest and lowest targets is 26.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for RCEL.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 3 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $10.79 | -17.32% |
| Average target | $12.03 | -7.82% |
| High target | $13.66 | +4.67% |